The North America & APAC Infusion Pumps Market was valued at USD 4,150 Million in 2025 and is expected to reach USD 8,390 Million by 2035, growing at a CAGR of 7.1% from 2024 to 2035. This market report presents a comprehensive analysis of current trends, growth drivers, and opportunities as well as historical market revenue, future projections, and recent developments shaping the global landscape.
The economic impact of tariffs on "North America APAC Infusion Pumps Market".
Market Growth Drivers
Increasing Prevalence of Chronic Diseases: The rising incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is driving the demand for infusion pumps across North America and APAC. With the growing population of elderly patients who require long-term care and medication administration, the market for infusion pumps is significantly expanding. For instance, Medtronic plc reported a surge in demand for their infusion pump solutions tailored to diabetic and oncology patients, supporting continuous and precise drug delivery.
Technological Advancements and Integration with Digital Health: Advancements in infusion pump technology, such as smart pumps equipped with wireless connectivity and integration with electronic health records (EHR), are boosting market growth. Becton, Dickinson and Company (BD) introduced their latest BD Alaris™ Infusion System, which offers advanced drug library features and remote monitoring, enhancing patient safety and workflow efficiency for healthcare providers.
Market Trends
Adoption of Wireless and Cloud-Connected Pumps: There is a growing trend towards the adoption of wireless and cloud-connected infusion pumps, which enable centralized monitoring and data collection. Companies like Baxter International Inc. have launched integrated solutions such as the Spectrum IQ Infusion System, allowing healthcare professionals to monitor infusion parameters remotely, reduce medication errors, and streamline operational efficiency.
Rising Use of Ambulatory and Home Infusion Pumps: The shift towards home-based healthcare and ambulatory infusion therapy is gaining momentum, especially in North America and APAC post-pandemic. Hospira, a Pfizer company, is investing in portable infusion pump product lines designed for home care settings, enabling patients to manage their conditions efficiently outside the hospital environment.
Market Opportunities
Expansion into Emerging Economies: Companies are increasingly looking to expand their footprint in emerging markets across APAC, such as India and Southeast Asia, where the demand for advanced medical devices is rising due to improved healthcare infrastructure and increased healthcare expenditure.
Partnerships and Integrations with Digital Health Startups: There is significant opportunity for traditional infusion pump manufacturers to partner with digital health startups to develop next-generation smart pumps integrated with AI and predictive analytics to further improve dosing precision and patient safety.
North America & APAC Infusion Pumps Market Revenue (USD Million), 2020-2035
The revenue chart illustrates a steady and robust growth in the North America & APAC Infusion Pumps Market from USD 2,400 Million in 2020 to USD 8,390 Million projected by 2035. Key drivers for this upward trend include technological advancements, increasing prevalence of chronic diseases, and the growing preference for home-based and ambulatory care solutions. Between 2024 and 2035, the market demonstrates accelerated growth, fueled by enhanced connectivity and expansion into emerging economies. The chart underscores the long-term market potential and the continuing adoption of innovative infusion pump solutions across healthcare settings.
North America & APAC Infusion Pumps Market by Regions Share (%), 2025
The pie chart demonstrates that in 2025, North America will account for 48% of the infusion pump market, followed by China (18%), Japan (12%), India (10%), and Rest of APAC (12%). North America's dominance is attributed to its advanced healthcare infrastructure and early adoption of smart medical technologies. China and India are emerging as high-growth regions due to increasing healthcare investments and an expanding patient base. Japan holds a significant share, leveraging strong medical device manufacturing capabilities, while the rest of APAC collectively mirrors the rising adoption in other developing nations. This regional distribution highlights strategic growth and localization opportunities.
Recent Developments
In March 2024, Medtronic plc announced regulatory clearance for its new MiniMed 780G advanced hybrid closed-loop system in Canada, integrating advanced infusion pump and glucose monitoring features for Type 1 diabetes patients. This marks a significant milestone in offering more automated and connected pump solutions across North America and APAC.
In May 2024, Baxter International Inc. partnered with a leading health IT startup in Singapore to develop a next-generation smart infusion pump platform incorporating AI-driven dosage recommendations. The collaboration seeks to accelerate commercial introduction across selected APAC hospitals as early as 2025.
BD (Becton, Dickinson and Company) launched an upgraded cloud-based drug library for the Alaris™ Infusion System in May 2024. This rollout enhances clinical decision support and compliance with medication safety standards, reflecting continued investment in digital health and integration across North America and APAC hospitals.
Press Releases